Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Vogel

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group projectC L Vogel, R V Smalley, M Raney, et al.
Journal of Pain and Symptom Management|August 1, 1991
Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomitingM Lane, C L Vogel, J Ferguson, et al.
Blood|September 1, 1980
Studies on levamisole--induced agranulocytosisJ S Thompson, J M Herbick, L W Klassen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 11, 1992
Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) TrialE Vélez-García, J T Carpenter, M Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study GroupA Buzdar, W Jonat, A Howell, et al.
Cancer|September 18, 1998
Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study GroupA U Buzdar, W Jonat, A Howell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic diseaseM A Cobleigh, C L Vogel, D Tripathy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancerD F Hayes, J A Van Zyl, A Hacking, et al.
Cancer|November 15, 1990
A phase I study of 4'-0-tetrahydropyranyladriamycin. Clinical pharmacology and pharmacokineticsK S Sridhar, T S Samy, R P Agarwal, et al.
American Journal of Hematology|January 1, 1980
Mechanisms of levamisole-induced granulocytopenia in breast cancer patientsC L Vogel, M A Silverman, P W Mansell, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group projectC L Vogel, R V Smalley, M Raney, et al.
Journal of Pain and Symptom Management|August 1, 1991
Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomitingM Lane, C L Vogel, J Ferguson, et al.
Blood|September 1, 1980
Studies on levamisole--induced agranulocytosisJ S Thompson, J M Herbick, L W Klassen, et al.
European Journal of Cancer (Oxford, England : 1990)|January 11, 1992
Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) TrialE Vélez-García, J T Carpenter, M Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study GroupA Buzdar, W Jonat, A Howell, et al.
Cancer|September 18, 1998
Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study GroupA U Buzdar, W Jonat, A Howell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic diseaseM A Cobleigh, C L Vogel, D Tripathy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancerD F Hayes, J A Van Zyl, A Hacking, et al.
Cancer|November 15, 1990
A phase I study of 4'-0-tetrahydropyranyladriamycin. Clinical pharmacology and pharmacokineticsK S Sridhar, T S Samy, R P Agarwal, et al.
American Journal of Hematology|January 1, 1980
Mechanisms of levamisole-induced granulocytopenia in breast cancer patientsC L Vogel, M A Silverman, P W Mansell, et al.
Pageof 6